TP53 and cancer: In conjunction with the DEGs identified between the resistant and non-resistant subgroups, GO and KEGG enrichment analyses revealed 2165 enriched GO entries and 106 enriched KEGG entries, respectively, incorporating response to oxygen/hypoxia, carbon metabolism, proteoglycans in cancer, and the p53 signaling pathway (Figures 3F, G, Supplementary Table 9).